Analystreport

PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS) is now covered by analysts at Cowen Inc. They set an "outperform" rating on the stock.

PhaseBio Pharmaceuticals, Inc.  (PHAS) 
Last phasebio pharmaceuticals, inc. earnings: 3/30 08:01 am Check Earnings Report